FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2500129969> ?p ?o ?g. }

• W2500129969 abstract "Glioblastomas are among the most aggressive human cancers, and prognosis remains poor despite pres- ently available therapies. Angiogenesis is a hallmark of glioblastoma, and the resultant vascularity is associated with poor prognosis. The proteins that mediate angiogen- esis, including vascular endothelial growth factor (VEGF) signaling proteins, have emerged as attractive targets for therapeutic development. Since VEGF receptor-2 (VEG- FR-2) is thought to be the primary receptor mediating angiogenesis, direct inhibition of this receptor may produce an ideal therapeutic effect. In this context, we tested the therapeutic effect of CT322, a selective inhibitor of VEGFR-2. Using an intracranial murine xenograft model (U87-EGFRvIII-luciferase), we demonstrate that CT322 inhibited glioblastoma growth in vivo and prolonged sur- vival. Of note, the anti-neoplastic effect of CT322 is aug- mented by the incorporation of temozolomide or temozolomide with radiation therapy. Immunohistochemi- cal analysis of CT322 treated tumors revealed decreased CD31 staining, suggesting that the tumoricidal effect is mediated by inhibition of angiogenesis. These pre-clinical results provide the foundation to further understand long term response and tumor escape mechanisms to anti-angio- genic treatments on EGFR over-expressing glioblastomas." @default.
• W2500129969 created "2016-08-23" @default.
• W2500129969 creator A5018381770 @default.
• W2500129969 creator A5026878273 @default.
• W2500129969 creator A5033022984 @default.
• W2500129969 creator A5033509023 @default.
• W2500129969 creator A5035158926 @default.
• W2500129969 creator A5046099296 @default.
• W2500129969 creator A5062275248 @default.
• W2500129969 creator A5063497438 @default.
• W2500129969 creator A5070549399 @default.
• W2500129969 creator A5072414425 @default.
• W2500129969 date "2012-01-01" @default.
• W2500129969 modified "2023-09-27" @default.
• W2500129969 title "CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy J. Dawn WatersCarlos SanchezAyguen SahinDiahnn Futalan • David D. GondaJustin K. ScheerJohnny AkersKamalakannan Palanichamy • Peter WatermanArnab ChakravartiRalph WeisslederBrent Morse • Nick MarshEric FurfineClark C. ChenIrvith CarvajalBob S. Carter" @default.
• W2500129969 cites W1964261166 @default.
• W2500129969 cites W1967587727 @default.
• W2500129969 cites W1982859282 @default.
• W2500129969 cites W1986718067 @default.
• W2500129969 cites W1988917963 @default.
• W2500129969 cites W2003450086 @default.
• W2500129969 cites W2003598961 @default.
• W2500129969 cites W2006202974 @default.
• W2500129969 cites W2009855429 @default.
• W2500129969 cites W2027216690 @default.
• W2500129969 cites W2036264929 @default.
• W2500129969 cites W2053214209 @default.
• W2500129969 cites W2053375897 @default.
• W2500129969 cites W2064876412 @default.
• W2500129969 cites W2068666805 @default.
• W2500129969 cites W2069900390 @default.
• W2500129969 cites W2071752743 @default.
• W2500129969 cites W2096287682 @default.
• W2500129969 cites W2096415778 @default.
• W2500129969 cites W2102488910 @default.
• W2500129969 cites W2113012900 @default.
• W2500129969 cites W2114098415 @default.
• W2500129969 cites W2128687105 @default.
• W2500129969 cites W2130284499 @default.
• W2500129969 cites W2132607958 @default.
• W2500129969 cites W2138474842 @default.
• W2500129969 cites W2142154080 @default.
• W2500129969 cites W2142534649 @default.
• W2500129969 cites W2153400235 @default.
• W2500129969 cites W2157808018 @default.
• W2500129969 cites W2163458899 @default.
• W2500129969 cites W2167923186 @default.
• W2500129969 cites W2247406157 @default.
• W2500129969 cites W2337865916 @default.
• W2500129969 hasPublicationYear "2012" @default.
• W2500129969 type Work @default.
• W2500129969 sameAs 2500129969 @default.
• W2500129969 citedByCount "0" @default.
• W2500129969 crossrefType "journal-article" @default.
• W2500129969 hasAuthorship W2500129969A5018381770 @default.
• W2500129969 hasAuthorship W2500129969A5026878273 @default.
• W2500129969 hasAuthorship W2500129969A5033022984 @default.
• W2500129969 hasAuthorship W2500129969A5033509023 @default.
• W2500129969 hasAuthorship W2500129969A5035158926 @default.
• W2500129969 hasAuthorship W2500129969A5046099296 @default.
• W2500129969 hasAuthorship W2500129969A5062275248 @default.
• W2500129969 hasAuthorship W2500129969A5063497438 @default.
• W2500129969 hasAuthorship W2500129969A5070549399 @default.
• W2500129969 hasAuthorship W2500129969A5072414425 @default.
• W2500129969 hasConcept C126322002 @default.
• W2500129969 hasConcept C150903083 @default.
• W2500129969 hasConcept C151730666 @default.
• W2500129969 hasConcept C167734588 @default.
• W2500129969 hasConcept C207001950 @default.
• W2500129969 hasConcept C2776694085 @default.
• W2500129969 hasConcept C2777025900 @default.
• W2500129969 hasConcept C2777292972 @default.
• W2500129969 hasConcept C2777389519 @default.
• W2500129969 hasConcept C2778227246 @default.
• W2500129969 hasConcept C2778939058 @default.
• W2500129969 hasConcept C2779343474 @default.
• W2500129969 hasConcept C2780394083 @default.
• W2500129969 hasConcept C502942594 @default.
• W2500129969 hasConcept C509974204 @default.
• W2500129969 hasConcept C71924100 @default.
• W2500129969 hasConcept C86803240 @default.
• W2500129969 hasConcept C98274493 @default.
• W2500129969 hasConceptScore W2500129969C126322002 @default.
• W2500129969 hasConceptScore W2500129969C150903083 @default.
• W2500129969 hasConceptScore W2500129969C151730666 @default.
• W2500129969 hasConceptScore W2500129969C167734588 @default.
• W2500129969 hasConceptScore W2500129969C207001950 @default.
• W2500129969 hasConceptScore W2500129969C2776694085 @default.
• W2500129969 hasConceptScore W2500129969C2777025900 @default.
• W2500129969 hasConceptScore W2500129969C2777292972 @default.
• W2500129969 hasConceptScore W2500129969C2777389519 @default.
• W2500129969 hasConceptScore W2500129969C2778227246 @default.
• W2500129969 hasConceptScore W2500129969C2778939058 @default.
• W2500129969 hasConceptScore W2500129969C2779343474 @default.
• W2500129969 hasConceptScore W2500129969C2780394083 @default.
• W2500129969 hasConceptScore W2500129969C502942594 @default.
• W2500129969 hasConceptScore W2500129969C509974204 @default.
• W2500129969 hasConceptScore W2500129969C71924100 @default.
• W2500129969 hasConceptScore W2500129969C86803240 @default.
• W2500129969 hasConceptScore W2500129969C98274493 @default.

• next